These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2361563)

  • 1. Determination of replacement and suppressive doses of thyroxine.
    Banovac K; Carrington SA; Levis S; Fill MD; Bilsker MS
    J Int Med Res; 1990; 18(3):210-8. PubMed ID: 2361563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the optimal thyroxine dose with the TRH test for replacement and suppression therapy].
    Erne P; Staub JJ; Althaus B; Fleig Y; Girard J
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1922-3. PubMed ID: 6420884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
    Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
    J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
    Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seasonal variation of serum thyrotropin concentration and thyrotropin response to thyrotropin-releasing hormone in patients with primary hypothyroidism on constant replacement dosage of thyroxine.
    Konno N; Morikawa K
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1118-24. PubMed ID: 6804476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders.
    Bartalena L; Martino E; Falcone M; Buratti L; Grasso L; Mammoli C; Pacchiarotti A; Aghini-Lombardi F; Balzano S; Pinchera A
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1265-71. PubMed ID: 3680483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Test for recovery from hypothyroidism during thyroxine therapy in Hashimoto's thyroiditis.
    Takasu N; Komiya I; Asawa T; Nagasawa Y; Yamada T
    Lancet; 1990 Nov; 336(8723):1084-6. PubMed ID: 1977978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrous patients.
    Bartalena L; Martino E; Pacchiarotti A; Grasso L; Aghini-Lombardi F; Buratti L; Bambini G; Breccia M; Pinchera A
    J Clin Endocrinol Metab; 1987 Apr; 64(4):849-55. PubMed ID: 3818906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentrations of osteocalcin in patients with hyperthyroidism, hypothyroidism and subacute thyroiditis.
    Kojima N; Sakata S; Nakamura S; Nagai K; Takuno H; Ogawa T; Matsui I; Sarui H; Miura K
    J Endocrinol Invest; 1992; 15(7):491-6. PubMed ID: 1447487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in serum triiodothyronine, thyroxine, and thyrotropin during treatment with thyroxine in severe primary hypothyroidism.
    Maeda M; Kuzuya N; Masuyama Y; Imai Y; Ikeda H
    J Clin Endocrinol Metab; 1976 Jul; 43(1):10-7. PubMed ID: 947930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to thyrotropin releasing hormone: an objective criterion for the adequacy of thyrotropin suppression therapy.
    Hoffman DP; Surks MI; Oppenheimer JH; Weitzman ED
    J Clin Endocrinol Metab; 1977 May; 44(5):892-901. PubMed ID: 404309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on replacement and suppressive dosages of 1-thyroxine.
    Nilsson G; Pettersson U; Levin K; Hughes R
    Acta Med Scand; 1977; 202(4):257-60. PubMed ID: 920242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effect of exogenous thyroxine dose on serum thyroxine and thyrotrophin levels in treated hypothyroid patients.
    Soppi E; Irjala K; Kaihola HL; Viikari J
    Scand J Clin Lab Invest; 1984 Jun; 44(4):353-6. PubMed ID: 6463564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference in pituitary-thyroid feedback regulation in hypothyroid patients, depending on the severity of hypothyroidism.
    Aizawa T; Koizumi Y; Yamada T; Tawata M; Nagata H; Izumiyama T; Yoshizawa K
    J Clin Endocrinol Metab; 1978 Sep; 47(3):560-5. PubMed ID: 263732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital goitrous hypothyroidism: discordant systolic time intervals, pituitary and peripheral responses to high daily doses of T4 or T3 therapy.
    Cavaliere H; Savioli R; Lima E; Medeiros-Neto GA
    J Endocrinol Invest; 1984 Aug; 7(4):367-72. PubMed ID: 6438221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individually-tailored thyroxine requirement in the same patients before and after thyroidectomy: a longitudinal study.
    Del Duca SC; Santaguida MG; Brusca N; Gatto I; Cellini M; Gargano L; Verga Falzacappa C; Frattaroli FM; Virili C; Centanni M
    Eur J Endocrinol; 2015 Sep; 173(3):351-7. PubMed ID: 26092761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
    Bayer MF; Kriss JP; McDougall IR
    J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of overt and subclinical hypothyroidism. Factors influencing L-thyroxine dosage.
    Rezzónico JN; Pusiol E; Saravi FD; Rezzónico M; Bossa N
    Medicina (B Aires); 1999; 59(6):698-704. PubMed ID: 10752211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroxine may decrease serum thyroxine-binding globulin levels.
    Lin JY; Hwu-Liaw SE; Chang TC
    Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):342-5. PubMed ID: 2507733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine.
    Fiore E; Rago T; Latrofa F; Provenzale MA; Piaggi P; Delitala A; Scutari M; Basolo F; Di Coscio G; Grasso L; Pinchera A; Vitti P
    Endocr Relat Cancer; 2011 Aug; 18(4):429-37. PubMed ID: 21565972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.